Page last updated: 2024-08-25

clarithromycin and Disease Models, Animal

clarithromycin has been researched along with Disease Models, Animal in 116 studies

Research

Studies (116)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	26 (22.41)	18.2507
2000's	46 (39.66)	29.6817
2010's	40 (34.48)	24.3611
2020's	4 (3.45)	2.80

Authors

Authors	Studies
Matsuda, K; Matsumoto, S; Matsumoto, Y; Sasaki, H; Takasugi, H; Yoshida, Y	1
Kasahara, K; Kita, E; Mikasa, K; Mizuno, F; Nishi, K; Yasuda, Y	1
Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T	1
Castelletti, S; Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Orlando, F; Riva, A; Rocchi, M; Saba, V; Scalise, G; Silvestri, C	1
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Yamada, K; Yamamoto, Y; Yanagihara, K	1
Domon, H; Hirayama, S; Hiyoshi, T; Isono, T; Maekawa, T; Sasagawa, K; Tamura, H; Terao, Y; Yanagihara, K	1
Crumrine, M; Hewitt, JA; Slay, RM	1
A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X	1
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z	1
Cai, H; Gan, L; Guo, E; Huang, J; Lu, Y; Sun, C; Thapa, N; Wang, B; Xia, M; Zhou, B	1
Agius, JE; Emery, JP; Phalen, DN; Rose, K	1
Abe, T; Lee Fujimoto, K; Mutsuga, M; Narita, Y; Oshima, H; Tokuda, Y; Uchida, W; Usui, A; Yamawaki-Ogata, A	1
Aktan, B; Ersoy, B; Kilic, K; Sakat, MS; Sipal, S	1
Bergamini, G; Boaretti, M; Boschi, F; Cremonini, E; Lleo, M; Melotti, P; Ortombina, A; Sandri, A; Sorio, C	1
Almeida, DV; Converse, PJ; Grosset, JH; Lee, J; Li, SY; Nuermberger, EL; Omansen, TF	1
Atilgan, R; Başpınar, M; Ilhan, N; Pala, Ş; Yavuzkır, Ş; Yılmaz, M	1
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J	1
Arabkari, V; Eslami, M; Jazayeri Moghadas, A; Kokhaei, P; Niazi, Z; Sadighi Moghadam, B; Yousefi, B	1
Chai, CY; Chen, IJ; Chung, PW; Huang, HT; Kuo, MS; Liu, CP; Wu, BN	1
Karmakar, S; Padman, A; Sen, T; Swamy Mane, N	1
Giamarellos-Bourboulis, EJ; Karagianni, V; Liakou, P; Menenakos, E; Sabracos, L; Spyridaki, A; Tsaganos, T; Tsovolou, EC; Tzepi, IM; Zografos, G	1
Huang, X; Li, C; Li, J; Li, Y; Su, T; Zhang, Y	1
Akagawa, KS; Hirose, T; Kobayashi, K; Nagao, T; Nakayama, T; Ōmura, S; Oshima, M; Sugamata, R; Sugawara, A; Sunazuka, T; Suzuki, K; Yamamoto, K	1
Du, FC; Fu, Q; Gan, le L; Guo, G; Liu, KY; Sun, HW; Yue, ZY; Zhang, WJ; Zhang, Y; Zou, QM	1
Bansal, S; Chhibber, S	1
Aksoy, A; Arslan, S; Gacar, A; Genc, G; Guvenc, T; Koyuncu, M; Kurnaz, SC; Kutlar, G	1
Arnold, RD; Berghaus, LJ; Burton, AJ; Giguère, S; Hondalus, MK	1
Aoki, H; Itai, S; Iwao, Y; Mizoguchi, M; Noguchi, S	1
Beckett, EL; Essilfie, AT; Foster, PS; Gibson, PG; Hansbro, PM; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Simpson, JL; Starkey, MR	1
Cho, YJ; Heo, RW; Jeong, YY; Kang, KM; Lee, JD; Lee, SJ; Roh, GS; Song, DH; Yi, CO	1
Ambati, BK; Archer, B; Cho, YK; Das, SK; Uehara, H	1
Aktan, B; Kara, A; Kozan, G; Kurt, S; Öner, F; Sakat, MS	1
Cavkaytar, S; Erdem, O; Goktolga, U; Kiykac Altinbas, S; Tapisiz, A; Tapisiz, OL	1
Böttger, EC; Bruhn, DF; Lee, RE; Lenaerts, AJ; Liu, J; Meibohm, B; Scherbakov, D; Scherman, MS	1
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S	1
Hara, A; Harada, T; Ishimatsu, Y; Izumikawa, K; Kakugawa, T; Kohno, S; Kosai, K; Morita, T; Mukae, H; Nakashima, S; Sakamoto, N; Yanagihara, K	1
Ariza, J; Cabellos, C; Cabo, J; El Haj, C; Garcia-Somoza, D; Murillo, O; Ribera, A; Tubau, F	1
Demir, K; Duman, N; Kargi, A; Kumral, A; Ozkan, H; Sarioglu, S; Yesilirmak, DC; Yilmaz, O	1
Bosnjak, B; Eraković Haber, V; Glojnarić, I; Hrvacić, B; Kramarić, MD; Pasalić, I; Situm, K; Tkalcević, VI	1
Li, X; Sun, N; Wang, J; Xiong, L	1
Esposito, S; Gomez, AM; Hardy, RD; Katz, K; Mejias, A; Principi, N; Salvatore, CM; Tagliabue, C; Techasaensiri, C; Torres, JP	1
Asano, Y; Kashimura, M; Kobayashi, D; Nakanishi, Y; Okuyama, S; Sakurai, T; Shapiro, SD; Takayama, K; Yoneda, Y	1
Bosnar, M; Bosnjak, B; Eraković Haber, V; Ferencić, Z; Glojnarić, I; Hrvacić, B	1
Fujioka, Y; Kamiya, S; Kurata, S; Sasaki, T; Taguchi, H	1
Ergin, H; Özdemir, ÖM; Şimşek, NG; Türk, NŞ; Yenisey, Ç	1
Fu, L; Li, P; Liang, BW; Lu, Y; Wang, B; Zhao, WJ; Zheng, MQ	1
Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K	1
Ishinaga, H; Kitano, M; Majima, Y; Shimizu, T; Takeuchi, K	1
Ahmad, Z; Almeida, D; Converse, PJ; Dooley, KE; Grosset, JH; Nuermberger, EL	1
Atmatzidis, K; Atmatzidis, S; Chatzimavroudis, G; Giamarellos-Bourboulis, EJ; Koutelidakis, I; Louis, K; Pistiki, A; Roditis, K	1
Brescini, L; Cirioni, O; Gabrielli, E; Ghiselli, R; Giacometti, A; Guerrieri, M; Minardi, D; Muzzonigro, G; Orlando, F; Rimini, M; Silvestri, C	1
Ding, FM; Jiang, YQ; Shen, C; Zhu, SL	1
Bosnar, M; Bosnjak, B; Cuzic, S; Erakovic Haber, V; Glojnaric, I; Hrvacic, B; Ivetic Tkalcevic, V	1
Choi, GE; Daley, CL; Hahn, MY; Jeon, K; Jeong, BH; Kim, S; Koh, WJ; Lee, K; Lee, SH; Min, KN; Oh, T; Shin, SJ; Won, CJ	1
Fukuno, Y; Hayashi, S; Kawashima, M; Nagata, M; Tominaga, M; yatsunami, J	1
Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J	1
Doern, GV; Ernst, EJ; Hoffman, HL; Klepser, ME; Petzold, CR; Sa'adah, LM	1
Chavez-Bueno, S; Hardy, RD; Hatfield, J; Jafri, HS; McCracken, GH; Ramilo, O; Rios, AM; Rogers, BB	1
Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS	1
Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ	1
Gabazza, EC; Hattori, R; Majima, Y; Shimizu, S; Shimizu, T	1
Cynamon, MH; DeStefano, MS; Elliott, SA; Yeo, AE	1
Ahn, CY; Chung, SJ; Kim, EJ; Kim, SG; Kwon, JW; Lee, MG; Shim, CK	1
Asano, K; Hirakata, Y; Kadota, J; Kaneko, Y; Kawano, S; Kuroki, M; Miyazaki, Y; Mukai, H; Tashiro, T; Yanagihara, K	1
Shiroki, K	1
Banevicius, MA; Capitano, B; Geng, Q; Maglio, D; Nicolau, DP; Nightingale, CH	1
Avozani, M; Camozzato, C; Jones, MH; Machado, DC; Pinto, LA; Pitrez, PM; Stein, RT	1
Cynamon, MH; Sklaney, M; Yeo, AE	1
Dick, JD; Hose, S; Hyon, JY; Joo, MJ; O'Brien, TP; Sinha, D	1
Bayarslan, C; Bayramoğlu, A; Celik, HH; Kandemir, O; Kaya, A; Milcan, A; Oztuna, V	1
Banevicius, MA; Du, X; Lee, SY; Maglio, D; Nicolau, DP; Sun, HK	1
Asano, K; Gyo, H; Heisha, Y; Higashiyama, Y; Kaneko, Y; Kawano, S; Miyazaki, Y; Monda, J; Ono, H; Tashiro, T; Yanagihara, K	1
Fujiwara, H; Ihara, T; Imano, R; Shibahara, H; Sugamata, M; Suzuki, M; Uchide, I	1
Adamis, T; Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koutoukas, P; Raftogiannis, M; Sabracos, L; Tziortzioti, V	1
Ellis, MC; Ellis, MW; Griffith, ME; Hawley, JS; Hospenthal, DR; McCall, S; Moon, JE; Murray, CK; Rivard, RG	1
Higashiyama, Y; Higuchi, N; Hirakata, Y; Kadota, J; Kohno, S; Kuroki, M; Miyazaki, Y; Mizuta, Y; Mukae, H; Ohno, H; Tomono, K; Tsukamoto, K; Yanagihara, K	1
Aono, Y; Azuma, M; Inayama, M; Izumi, K; Kinoshita, K; Kishi, J; Makino, H; Nishioka, Y; Ogushi, F; Shono, M; Sone, S; Uehara, H	1
Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK	1
Cohen, Y; Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL	1
Graybill, JR; Moreno, F; Valero, G	1
Hughes, WT; Killmar, JT; Oz, HS	1
Alder, J; Clement, JC; Hutch, T; Meulbroek, JA	1
Cynamon, MH; Grossi, MA; Klemens, SP	1
Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Vilde, JL	1
Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R	1
Alder, J; Clement, J; Gupta, P; Jarvis, K; Mitten, M	1
Ellis, W; Fayer, R	1
Baskerville, A; Fitzgeorge, RB; Lever, S	1
Cimochowski, CR; Faiella, JA; Girard, AE	1
Pocidalo, JJ; Veber, B	1
Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK	1
Bermudez, LE; Inderlied, CB; Nash, KA; Petrofsky, M; Young, LS	1
Bermudez, LE; Kolonoski, P; Petrofsky, M; Young, LS	1
Hamada, K; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, M; Tsujimoto, M	1
Asano, K; Hirakata, Y; Kadota, J; Kawano, S; Koga, H; Ogawa, K; Ono, H; Sawai, T; Shirai, R; Tashiro, T; Yamamoto, Y; Yanagihara, K	1
Akashi, T; Sone, S; Yamagishi, T; Yano, S	1
Barg, N	1
Calhoun, J; Mader, JT; Shirtliff, ME	1
Brun, S; Chen, J; Hegazy, H; Liang, C; Molinari, LC; Peyman, GA; Tarcha, PJ; Unal, M	1
Banevicius, MA; Bui, KQ; Nicolau, DP; Nightingale, CH; Quintiliani, R	1
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E	1
Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K	1
Higashiyama, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tomono, K; Yanagihara, K	1
Ishikawa, M; Majima, Y; Nakase, K; Sugawara, Y	1
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, S; Yoshimoto, E	1
Abe, S; Aoyama, A; Azuma, A; Enomoto, T; Kudo, S; Lee, Y; Matsuda, K; Miyamoto, H; Shinhara, R; Takahashi, S; Takahashi, T; Usuki, J	1
Kaisho, T; Kanamaru, T; Miyagawa, KI; Nakano, Y; Nakao, M; Tada, M; Toyoda, Y	1
Fujikawa, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K	1
Baird, SM; Carson, DA; Catanzaro, A; Hayashi, T; Kornbluth, RS; Rao, SP; Raz, E; Takabayashi, K; Taylor, MW; Van Uden, JH	1
Ebata, M; Keto, Y; Okabe, S	1
Kim, MK; Li, C; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W	1
Domon, H; Inoue, H; Ishii, C; Koga, T; Okazaki, Y; Utsui, Y	1
Cynamon, MH; DeStefano, MS; Klemens, SP	1
Grosset, JH; Ji, B; Perani, EG; Petinon, C	1
Chen, HY; Maskell, JP; Powell, M	1
Araujo, FG; Prokocimer, P; Remington, JS	1

Reviews

4 review(s) available for clarithromycin and Disease Models, Animal

Article	Year
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12 Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult	2022
Proceedings. Mathematical, physical, and engineering sciences, 2019, Volume: 475, Issue:2227 Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium	2019
Are probiotics useful for therapy of Helicobacter pylori diseases? Comparative immunology, microbiology and infectious diseases, 2019, Volume: 64 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Probiotics; Treatment Outcome	2019
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2001, Volume: 118, Issue:4 Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indomethacin; Omeprazole; Recurrence; Stomach Neoplasms; Stomach Ulcer	2001

Trials

1 trial(s) available for clarithromycin and Disease Models, Animal

Article

Year

Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.

Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult

2022

Other Studies

112 other study(ies) available for clarithromycin and Disease Models, Animal

Article	Year
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. Bioorganic & medicinal chemistry letters, 1999, Nov-01, Volume: 9, Issue:21 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clarithromycin; Disease Models, Animal; Helicobacter pylori; Lactams; Mice; Molecular Structure	1999
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Disease Models, Animal; Drug Resistance, Bacterial; Lung; Macrolides; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred CBA; Pneumonia, Pneumococcal; Roxithromycin; Streptolysins	2007
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens. Journal of medicinal chemistry, 2008, Apr-10, Volume: 51, Issue:7 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water	2008
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Clarithromycin; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Male; Peptides, Cyclic; Rats; Rats, Wistar; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha	2008
Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bronchioles; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Chemokine CXCL2; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-1beta; Male; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia; Pulmonary Alveoli	2010
Clarithromycin Inhibits Pneumolysin Production via Downregulation of Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Down-Regulation; Erythromycin; Humans; Lincosamides; Male; Mice; Mice, Inbred BALB C; Pneumonia; Protein Synthesis Inhibitors; Streptococcus pneumoniae; Streptolysins; Transcription, Genetic	2021
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-17, Volume: 75, Issue:Suppl 3 Topics: Animals; Anthrax; Anti-Bacterial Agents; Azithromycin; Bacillus anthracis; Clarithromycin; Disease Models, Animal; Levofloxacin; Macaca fascicularis; Respiratory Tract Infections	2022
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo. Journal of ovarian research, 2019, Nov-08, Volume: 12, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice; Ovarian Neoplasms; Reactive Oxygen Species; Xenograft Model Antitumor Assays	2019
Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics. Scientific reports, 2021, 07-05, Volume: 11, Issue:1 Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Models, Animal; Enrofloxacin; Enterococcus; Humans; Lizards	2021
The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm. Journal of vascular surgery, 2018, Volume: 68, Issue:6S Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Cells, Cultured; Clarithromycin; Disease Models, Animal; Elastin; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Macrophages; Male; Matrix Metalloproteinases, Secreted; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-kappa B; Phosphorylation; Vascular Remodeling	2018
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs. The Journal of laryngology and otology, 2018, Volume: 132, Issue:7 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Ear, Middle; Erythromycin; Guinea Pigs; Histamine; Otitis Media with Effusion; Roxithromycin	2018
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. Virulence, 2018, Volume: 9, Issue:1 Topics: Animals; Bacterial Proteins; Clarithromycin; Cystic Fibrosis; Disease Models, Animal; Female; Humans; Interleukin-8; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors	2018
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Female; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Oxazolidinones; Rifampin; Tetrazoles	2019
What is the impact of short- and long-term supplementation of either cabergoline or clarithromycin on resolving rat ovarian hyperstimulation syndrome (OHSS) model? Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:5 Topics: Animals; Anti-Bacterial Agents; Cabergoline; Chorionic Gonadotropin; Clarithromycin; Disease Models, Animal; Dopamine Agonists; Estradiol; Female; Gonadotropins, Equine; Interleukin-10; Interleukin-1beta; Ovarian Hyperstimulation Syndrome; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2019
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin	2019
NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis. Pulmonary pharmacology & therapeutics, 2014, Volume: 27, Issue:1 Topics: Animals; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Piperidines; Pneumonia; Pulmonary Fibrosis; Signal Transduction; Simvastatin; Time Factors; Xanthines	2014
Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats. European journal of pharmacology, 2013, Jun-05, Volume: 709, Issue:1-3 Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Dietary Supplements; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Electrocardiography; Electrolytes; Furosemide; Heart; Hypokalemia; Male; Potassium, Dietary; Rats; Rats, Wistar; Risk Factors; Severity of Illness Index; Suspensions	2013
Effect of clarithromycin in experimental empyema by multidrug-resistant Pseudomonas aeruginosa. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:1 Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Apoptosis; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empyema, Pleural; Humans; Interleukin-6; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pleural Effusion; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tumor Necrosis Factor-alpha; U937 Cells	2014
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection. Drug delivery, 2015, Volume: 22, Issue:5 Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Daptomycin; Disease Models, Animal; Liposomes; Methicillin-Resistant Staphylococcus aureus; Mice; Polyethylene Glycols; Staphylococcal Infections; Treatment Outcome	2015
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression. The Journal of antibiotics, 2014, Volume: 67, Issue:3 Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate	2014
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pronase; Stomach	2014
Phytochemical-induced reduction of pulmonary inflammation during Klebsiella pneumoniae lung infection in mice. Journal of infection in developing countries, 2014, Jul-14, Volume: 8, Issue:7 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Malondialdehyde; Mice, Inbred BALB C; Nitric Oxide; Peroxidase; Pneumonia; Tumor Necrosis Factor-alpha	2014
Does systemic clarithromycin therapy have an inhibitory effect on tympanosclerosis? An experimental animal study. The Journal of laryngology and otology, 2015, Volume: 129, Issue:2 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Linear Models; Middle Ear Ventilation; Myringosclerosis; Otitis Media; Pneumococcal Infections; Random Allocation; Rats; Streptococcus pneumoniae; Tympanic Membrane	2015
Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages. Veterinary microbiology, 2015, Apr-17, Volume: 176, Issue:3-4 Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Gentamicins; Horse Diseases; Horses; Liposomes; Liver; Macrophages, Alveolar; Male; Mice; Mice, Nude; Pneumonia; Rhodococcus equi; Rifampin; Spleen	2015
Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2015, Volume: 92 Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Excipients; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Time Factors	2015
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. Thorax, 2015, Volume: 70, Issue:5 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C	2015
Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice. PloS one, 2015, Volume: 10, Issue:6 Topics: Animals; Apoptosis; Body Weight; Clarithromycin; Disease Models, Animal; Female; Fibrosis; Lung; Mice; Mice, Inbred C57BL; Radiation Pneumonitis; Radiation-Protective Agents	2015
Comparison of the Anti-angiogenic and Anti-inflammatory Effects of Two Antibiotics: Clarithromycin Versus Moxifloxacin. Current eye research, 2016, Volume: 41, Issue:4 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Cornea; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Immunohistochemistry; Keratitis; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Moxifloxacin	2016
Effect of systemic clarithromycin and prednisolone on histamine-induced otitis media in guinea pigs. Acta oto-laryngologica, 2015, Volume: 135, Issue:10 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ear, Middle; Glucocorticoids; Guinea Pigs; Histamine; Injections, Intraperitoneal; Male; Otitis Media with Effusion; Prednisolone	2015
Clarithromycin regresses endometriotic implants in rat endometriosis model. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2015, Volume: 35, Issue:8 Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Evaluation, Preclinical; Endometriosis; Female; Matrix Metalloproteinase 9; Protein Synthesis Inhibitors; Random Allocation; Rats, Wistar	2015
In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics. Scientific reports, 2015, Sep-14, Volume: 5 Topics: Acute Disease; Animals; Antitubercular Agents; Clarithromycin; Clindamycin; Disease Models, Animal; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Half-Life; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis	2015
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin	2015
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 358, Issue:3 Topics: Animals; Bacterial Load; Cell Count; Chemokines; Clarithromycin; Coinfection; Disease Models, Animal; Influenza A Virus, H1N1 Subtype; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Pneumonia, Bacterial; Pulmonary Emphysema; Streptococcus pneumoniae; Survival Analysis; Viral Load	2016
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance? Medical microbiology and immunology, 2017, Volume: 206, Issue:1 Topics: Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Daptomycin; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Foreign Bodies; Microbial Sensitivity Tests; Microbial Viability; Rats; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2017
Clarithromycin, montelukast, and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2008, Volume: 21, Issue:6 Topics: Acetates; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Bronchopulmonary Dysplasia; Clarithromycin; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Humans; Infant, Newborn; Leukotriene Antagonists; Oxygen Inhalation Therapy; Pentoxifylline; Quinolines; Rats; Sulfides	2008
The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice. International journal of antimicrobial agents, 2008, Volume: 32, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Clarithromycin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Shock, Septic; Treatment Outcome; Tumor Necrosis Factor-alpha	2008
[Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus]. Yan ke xue bao = Eye science, 2008, Volume: 24, Issue:1 Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Clarithromycin; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Gels; Rabbits; Staphylococcal Infections; Staphylococcus aureus	2008
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. The Journal of infectious diseases, 2008, Oct-15, Volume: 198, Issue:8 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Culture Media; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Humans; Lung; Mice; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Treatment Outcome	2008
Clarithromycin prevents smoke-induced emphysema in mice. American journal of respiratory and critical care medicine, 2009, Feb-15, Volume: 179, Issue:4 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Emphysema; Environmental Exposure; Female; Fluorescent Antibody Technique, Indirect; In Vitro Techniques; Lung; Lung Compliance; Macrophages; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Tobacco Smoke Pollution; Treatment Outcome	2009
Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma. European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Models, Animal; Immunologic Factors; Inflammation; Lung; Male; Mice; Ovalbumin; Respiratory System	2009
Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae. Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 6 Topics: Animals; Anti-Bacterial Agents; Cell Line; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Epithelial Cells; Female; Germ-Free Life; Humans; Immunologic Factors; Japan; Macrolides; Mice; Mycoplasma pneumoniae; Pneumonia, Mycoplasma	2010
Protective effects of clarithromycin in rats with hypoxia/reoxygenation-induced intestinal injury. Journal of pediatric surgery, 2010, Volume: 45, Issue:11 Topics: Animals; Animals, Newborn; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Necrotizing; Glutathione; Ileum; Injections, Subcutaneous; Intestinal Mucosa; Lipid Peroxidation; Malondialdehyde; Nitric Oxide; Oxidative Stress; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; Treatment Outcome	2010
[A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2010, Volume: 33, Issue:9 Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2010
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin	2011
Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea. Pharmacology, 2011, Volume: 87, Issue:1-2 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Dexamethasone; Disease Models, Animal; Glucocorticoids; Goblet Cells; Lipopolysaccharides; Male; Metaplasia; Mucus; Rats; Rats, Inbred F344; Secretory Pathway; Severity of Illness Index; Trachea; Tracheitis; Transplantation, Isogeneic; Viscosity	2011
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice. PLoS neglected tropical diseases, 2011, Jan-04, Volume: 5, Issue:1 Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Treatment Outcome	2011
Clarithromycin modulates immune responses in experimental peritonitis. International journal of antimicrobial agents, 2011, Volume: 37, Issue:4 Topics: Animals; Anti-Bacterial Agents; Apoptosis; Clarithromycin; Disease Models, Animal; Flow Cytometry; Lymphocytes; Male; Peritonitis; Rabbits	2011
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6 Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Coated Materials, Biocompatible; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Stents; Ureteral Diseases	2011
Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. Respirology (Carlton, Vic.), 2012, Volume: 17, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage; Clarithromycin; Disease Models, Animal; Female; Immunohistochemistry; Interleukin-17; Interleukin-4; Lung Diseases; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Respiratory Tract Infections; Stem Cells; T-Lymphocytes, Regulatory	2012
Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. Translational research : the journal of laboratory and clinical medicine, 2012, Volume: 160, Issue:2 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Cantharidin; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Ear, External; Edema; Irritants; Male; Mice; Mice, Inbred Strains; Otitis Externa; Translational Research, Biomedical	2012
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. American journal of respiratory and critical care medicine, 2012, Nov-01, Volume: 186, Issue:9 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bone Marrow Cells; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Humans; In Vitro Techniques; Macrolides; Mice; Mice, Inbred C57BL; Mycobacterium; Mycobacterium Infections, Nontuberculous; Republic of Korea	2012
Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. Lung, 2002, Volume: 180, Issue:2 Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Apoptosis; Azithromycin; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Growth Substances; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Josamycin; Lung; Male; Mice; Mice, Inbred ICR; Pulmonary Edema; Respiratory Distress Syndrome; Roxithromycin; Time Factors; Treatment Outcome	2002
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10 Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer	2002
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:2 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Half-Life; Humans; Lung Diseases; Mice; Microbial Sensitivity Tests; Serotyping; Streptococcal Infections; Streptococcus pneumoniae	2003
Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5 Topics: Animals; Bronchoalveolar Lavage Fluid; Chemokines; Clarithromycin; Cytokines; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Plethysmography; Pneumonia, Mycoplasma	2003
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. The Journal of infectious diseases, 2003, Jun-15, Volume: 187, Issue:12 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Aza Compounds; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mefloquine; Mice; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines	2003
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum	2003
In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. American journal of respiratory and critical care medicine, 2003, Sep-01, Volume: 168, Issue:5 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Clarithromycin; Disease Models, Animal; Goblet Cells; Humans; In Vitro Techniques; Josamycin; Male; Mucus; Nasal Mucosa; Nose Neoplasms; Penicillins; Rats; Rats, Inbred F344; Respiratory Hypersensitivity; Secretory Rate	2003
Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infection. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:2 Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred C57BL; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii	2003
Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition. Life sciences, 2003, Aug-22, Volume: 73, Issue:14 Topics: Administration, Oral; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Clarithromycin; Cysteine; Disease Models, Animal; Injections, Intravenous; Male; Microsomes, Liver; Nutritional Status; Protein-Energy Malnutrition; Rats; Rats, Sprague-Dawley; Tissue Distribution	2003
[Effect of macrolide antibiotics on secretion of MUC5AC in murine model of diffuse panbronchiolitis and related diseases]. The Japanese journal of antibiotics, 2003, Volume: 56 Suppl A Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Bronchiolitis; Clarithromycin; Depression, Chemical; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Inbred Strains; Middle Aged; Mucin 5AC; Mucins; Pulmonary Fibrosis; Sarcoidosis, Pulmonary	2003
[Anti-influenza mechanism of macrolide antibiotics inducing airway IL-12 production in murine influenza model ]. The Japanese journal of antibiotics, 2003, Volume: 56 Suppl A Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Models, Animal; Female; Interferon-gamma; Interleukin-12; Mice; Mice, Inbred DBA; Orthomyxoviridae Infections	2003
Differential efficacy of clarithromycin in lung versus thigh infection models. Chemotherapy, 2004, Volume: 50, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae; Thigh	2004
Effect of clarithromycin on the cell profile of bronchoalveolar lavage fluid in mice with neutrophil-predominant lung disease. Revista do Hospital das Clinicas, 2004, Volume: 59, Issue:3 Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cell Count; Clarithromycin; Disease Models, Animal; Lung Diseases; Male; Mice; Neutrophils; Pseudomonas aeruginosa	2004
The activity of grepafloxacin in two murine models of Mycobacterium avium infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2004, Volume: 10, Issue:3 Topics: Administration, Intranasal; Animals; Clarithromycin; Disease Models, Animal; Ethambutol; Female; Fluoroquinolones; Injections, Intravenous; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Piperazines; Random Allocation; Rifabutin	2004
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:8 Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits	2004
Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clinical orthopaedics and related research, 2005, Issue:430 Topics: Animals; Anti-Bacterial Agents; Biofilms; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Microbial Sensitivity Tests; Osteomyelitis; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Radiography; Rats; Rats, Wistar; Reference Values	2005
Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:3 Topics: Administration, Oral; Amoxicillin; Animals; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Membrane Proteins; Methyltransferases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Pulse Therapy, Drug; Streptococcus pneumoniae	2005
[Analysis of the mechanism of suppression on MUC5AC by macrolides--an analysis by using a chronic airway infection model]. The Japanese journal of antibiotics, 2004, Volume: 57 Suppl A Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Disease Models, Animal; Male; Mice; Mucin 5AC; Mucins; Respiratory Tract Infections	2004
[Effects of clarithromycin on a rat endometriosis model: light and electron microscopic evaluation]. The Japanese journal of antibiotics, 2004, Volume: 57 Suppl A Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Endometriosis; Female; Microscopy, Electron; Rats; Rats, Sprague-Dawley	2004
Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:5 Topics: Acute Disease; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Immunologic Factors; Injections, Intravenous; Klebsiella pneumoniae; Male; Monocytes; Pyelonephritis; Rabbits; Tumor Necrosis Factor-alpha	2006
Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Doxycycline; Female; Ketolides; Leptospira interrogans; Leptospirosis; Macrolides; Mesocricetus; Serotyping; Species Specificity; Survival Analysis	2006
Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection. Chemotherapy, 2007, Volume: 53, Issue:1 Topics: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Ketolides; Lung; Lymphocytes; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	2007
Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice. American journal of respiratory and critical care medicine, 2007, Dec-15, Volume: 176, Issue:12 Topics: Animals; Benzamides; Cells, Cultured; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fibroblasts; Imatinib Mesylate; Macrolides; Mice; Orosomucoid; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines	2007
Effect of Helicobacter pylori eradication on gastric carcinogenesis. Laboratory investigation; a journal of technical methods and pathology, 2008, Volume: 88, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors	2008
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:3 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Female; Glucocorticoids; Humans; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen	1995
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:11 Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Skin Diseases, Bacterial; Splenic Diseases	1994
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model. The Journal of infectious diseases, 1994, Volume: 170, Issue:4 Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1994
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:11 Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mice; Minocycline; Pyrimethamine; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal	1994
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7 Topics: Animals; Azithromycin; Clarithromycin; Culture Media; Disease Models, Animal; Female; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen	1994
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Rifabutin; Rodent Diseases; Spleen; Time Factors; Tuberculosis	1993
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. American journal of ophthalmology, 1993, Dec-15, Volume: 116, Issue:6 Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin	1993
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:6 Topics: Animals; Antibodies, Bacterial; Borrelia burgdorferi Group; Clarithromycin; Cricetinae; Disease Models, Animal; Heart; Humans; Kidney; Lyme Disease; Mesocricetus; Microbial Sensitivity Tests; Spleen; Urinary Bladder	1993
Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. The Journal of parasitology, 1993, Volume: 79, Issue:4 Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Doxycycline; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred BALB C; Minocycline; Paromomycin; Tetracyclines	1993
A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl E Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Female; Guinea Pigs; Legionella pneumophila; Legionnaires' Disease; Lung	1993
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl E Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes	1993
[The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia]. Pathologie-biologie, 1995, Volume: 43, Issue:6 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Injections, Subcutaneous; Mice; Pneumonia, Pneumococcal; Roxithromycin; Spiramycin	1995
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. The American journal of gastroenterology, 1996, Volume: 91, Issue:11 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors	1996
Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. The Journal of infectious diseases, 1996, Volume: 174, Issue:6 Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Genes, Bacterial; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutagenesis, Site-Directed; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Ribosomal, 23S; Spleen	1996
Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Female; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen	1998
[Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Female; Immunologic Factors; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred Strains	1997
[Analysis of chronic respiratory tract infection by using an intubation model--evaluation based on fluctuations in cytokine content]. The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Intubation, Intratracheal; Male; Mice; Respiratory Tract Infections; Tumor Necrosis Factor-alpha	1997
[Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system]. The Japanese journal of antibiotics, 1998, Volume: 51 Suppl A Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Immunologic Factors; Lung Neoplasms; Mice; Mice, SCID; Neoplasms, Experimental	1998
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2 Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes	1998
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. Clinical orthopaedics and related research, 1999, Issue:359 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Biological Availability; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Nafcillin; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Tibia; Treatment Outcome	1999
Ocular toxicity of intravitreal clarithromycin. Retina (Philadelphia, Pa.), 1999, Volume: 19, Issue:5 Topics: Animals; Anti-Bacterial Agents; Cataract; Chromatography, High Pressure Liquid; Clarithromycin; Dark Adaptation; Disease Models, Animal; Electroretinography; Follow-Up Studies; Half-Life; Injections; Necrosis; Rabbits; Retina; Retinal Diseases; Vitreous Body	1999
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1 Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	2000
[Administration of clarithromycin (CAM) to non-small cell lung cancer]. The Japanese journal of antibiotics, 2000, Volume: 53 Suppl A Topics: Adenocarcinoma; Aged; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Disease Models, Animal; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-10; Interleukin-12; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL	2000
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:1 Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	2000
Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa. Clinical and experimental immunology, 2000, Volume: 122, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bronchiolitis; Clarithromycin; Cytokines; Disease Models, Animal; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-4; Interleukin-5; Lung; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tissue Extracts; Tumor Necrosis Factor-alpha	2000
[Effect of macrolides on rat models of airway hypersecretion]. The Japanese journal of antibiotics, 2001, Volume: 54 Suppl A Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Depression, Chemical; Disease Models, Animal; Lung Diseases, Obstructive; Male; Rats; Rats, Inbred F344; Respiratory Mucosa; Sputum	2001
[Suppression of non-small-cell lung carcinoma metastasis with clarithromycin]. The Japanese journal of antibiotics, 2001, Volume: 54 Suppl A Topics: Aged; Animals; Anti-Bacterial Agents; Bone Neoplasms; Brain Neoplasms; Carcinoma, Small Cell; Clarithromycin; Disease Models, Animal; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Retrospective Studies	2001
[Suppressive effect of 14-cyclol linkage macrolides on bleomycin-induced pulmonary fibrosis]. The Japanese journal of antibiotics, 2001, Volume: 54 Suppl A Topics: Animals; Anti-Bacterial Agents; Bleomycin; Clarithromycin; Disease Models, Animal; E-Selectin; Leukocyte Elastase; Male; Mice; Mice, Inbred ICR; Neutrophil Infiltration; P-Selectin; Pulmonary Fibrosis; Roxithromycin; Vascular Cell Adhesion Molecule-1	2001
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Indoles; Male; Microbial Sensitivity Tests; Penicillins; Stomach Diseases; Tryptophan-tRNA Ligase	2001
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:3 Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Bronchopneumonia; Clarithromycin; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome	2001
Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infection and immunity, 2001, Volume: 69, Issue:10 Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Disease Models, Animal; DNA; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Interferon-beta; Interferon-gamma; Interleukin-12; Macrophages; Mice; Mice, Knockout; Monocytes; Mycobacterium avium; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides; T-Lymphocytes; Thionucleotides; Tryptophan Oxygenase; Tuberculosis; Tumor Necrosis Factor-alpha	2001
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Lung; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Pneumonia, Pneumococcal; Streptococcus pneumoniae	2002
Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Diterpenes; Drug Synergism; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Stomach	2002
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11 Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis	1992
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1992, Volume: 60, Issue:4 Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin	1992
Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model. The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:5 Topics: Animals; Bacteremia; Clarithromycin; Disease Models, Animal; Drug Synergism; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C	1992
Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis. The Journal of infectious diseases, 1992, Volume: 165, Issue:4 Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Minocycline; Toxoplasmosis, Animal	1992